Plasma Cytokines and Portopulmonary Hypertension in Patients With Cirrhosis Waiting for Orthotopic Liver Transplantation

Angiology

Volumn 61, Issue 8, 2010, Pages 802-806

  Pellicelli, Adriano M ^a   Barbaro, Giuseppe ^b   Puoti, Claudio ^c   Guarascio, Paolo ^a   Lusi, Elena Angela ^a   Bellis, Lia ^c   D'ambrosio, Cecilia ^a   Villani, Roberto ^a   Vennarecci, Giovanni ^d   Liotta, Gianluca ^d   Ettore, Giuseppe ^d   Andreoli, Arnaldo ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Marino Hospital Rome   (Italy)

^d Azienda San Camillo Forlanini ^*  (Italy)

Author keywords

endothelin 1; hyperdynamic circulation; interleukin 6; liver cirrhosis; portopulmonary hypertension

Indexed keywords

CYTOKINE; ENDOTHELIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART CATHETERIZATION; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MIDDLE AGED; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PULMONARY HYPERTENSION;

CYTOKINES; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ENDOTHELIN-1; HEART CATHETERIZATION; HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78049434738     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319710369101     Document Type: Article

References (29)

1. Castro M., Krowka MJ, Schroeder DR, et al. Frequency and clinical implications of increased pulmonary artery pressure in liver transplantation. Mayo Clin Proc. 1996; 71(6):543-551.
2. Mandel SM, Groves BM. Pulmonary hypertension in liver disease. Clin Chest Med. 1996;17(1):17-33.
3. McDonnel PJ, Toye PA, Hutchins GM. Primary pulmonary hypertension and cirrhosis: are they related? Am Rev Respir Dis. 1983;127(4):437-441.
4. Taura P, Garcia-Valdecasas JC, Beltran J, et al. Moderate primary pulmonary hypertension in patients undergoing liver transplantation. Anaesth Analg. 1996;83(4):675-680.
5. Hadengue A, Benhayoun MK, Lebrec D, et al. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology. 1991;100(2):520-528.
6. Cacoub P, Dorent R, Nataf P, et al. Endothelin-1 in the lungs of patients with pulmonary hypertension. Cardiovasc Res. 1997; 33(1):196-200.
7. Dupuis J, Cernacek P, Tardif JC, et al. Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension. Am Heart J. 1998;135(4):614-620.
8. Rubens C, Ewert R, Halank M, et al. Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest. 2001;12(5):1562-1569.
9. Humbert M, Monti G, Brenot F, et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am Respir Crit Care Med. 1995;151(5):1628-1631.
10. Rich S, Dantzker DR, Ayres DR, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med. 1987;107(2):216-223.
11. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology. 2006;43(2 suppl 1):S121-S131.
12. Swanson KL, Krowka MJ. Screen for portopulmonary hypertension, especially in liver transplant candidates. Cleve Clin J Med. 2008;75(2):121-136.
13. Colle IO, Moreau R, Godinho E, et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology. 2003;37(2):401-409.
14. Angus PW. Role of endothelin in systemic and portal resistance in cirrhosis. Gut. 2006;55(9):1230-1232.
15. Moller S, Emmeluth C, Henriksen JH. Elevated circulating plasma endothelin-1 concentrations in cirrhosis. J Hepatol. 1993;19(2):285-290.
16. Nolte W, Ehrenreich H, Wiltfang J, et al. Systemic and splanchnic endothelin-1 plasma levels in liver cirrhosis before and after transjugular intrahepatic portosystemic shunt (TIPS). Liver. 2000;20(1):60-65.
17. Isobe H, Satoh M, Sakai H, Nawata H. Increased plasma endothelin-1 levels in patients with cirrhosis and esophageal varices. J Clin Gastroenterol. 1993;17(3):227-230.
18. Bruno CM, Sciacca C, Caruso L. Plasma endothelin-1 levels in liver cirrhosis. Int J Clin Lab Res. 2000;30(4):169-172.
19. Veglio F, Pinna G, Melchio R, et al. Plasma endothelin levels in cirrhotic subjects. J Hepatol. 1992;15(1-2):85-87.
20. Blendis L, Wong F. The hyperdynamic circulation in cirrhosis: an overview. Pharmacol Ther. 2001;89(3):221-231.
21. Malaguarnera M, DiFazio I, Romeo MA, et al. Elevation of IL6 levels in patients with chronic hepatitis due to hepatitis C virus. J Gastroenterol. 1997;32(2):211-215.
22. Antonelli A, Ferri C, Ferrari SM, et al. High interleukin 6 and tumor necrosis factor alfa serum levels in hepatitis infection associated or not with mixed cryoglobulinemia. Clin Rheumatol. 2009;28(6):1179-1185.
23. Eddahibi S, Chaouat A, Tu L, et al. Interleukin-6 gene polymorphism confers susceptibility to pulmonary hypertension in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3(6):475-476.
24. Tazi KA, Quioc JJ, Saada V, Bezeaud A, Lebrec D, Moreau R. Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M. J Hepatol. 2006;45(2):280-289.
25. Lopez-Talavera JC, Merrill WW, Groszmann RJ. Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal hypertensive rats. Gastroenterology. 1995;108(3):761-767.
26. Barbaro G, Lucchini A, Pellicelli AM, Grisorio B, Giancaspro G, Barbarini G. Highly active antiretroviral therapy compared with HAART and Bosentan in combination in patients with HIV associated pulmonary hypertension. Heart. 2006;92(8):1164-1166.
27. Hoeper MM, Halank M, Marx C, et al. Bosentan therapy for portopulmonary hypertension. Eur Respir J. 2005;25(3):502-508.
28. Tempe DK, Datt V, Datta D. Bosentan for the treatment of portopulmonary hypertension. Ann Card Anaesth. 2008;11(2):139-140.
29. Taniguchi K, Shimazaki C, Fujimoto Y, et al. Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease. Int J Hematol. 2009;90(1):99-102.